Biotech · Private company
Philogen S.p.A.
Track this companyFree. Adds Philogen S.p.A. to your Dealase workspace and tells you when its record changes.
Clinical trials86 recruiting or active
Pipeline programs17From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline17
- Adjuvant therapyPhase 3 · Melanoma Stage IIIBClinicalTrials.gov · fetched Nov 12, 2026
- DaromunPhase 3 · Melanoma Stage IIIBClinicalTrials.gov · fetched Nov 12, 2026
- SurgeryPhase 3 · Melanoma Stage IIIBClinicalTrials.gov · fetched Nov 12, 2026
- DoxorubicinPhase 2 · LeiomyosarcomaClinicalTrials.gov · fetched Nov 12, 2026
- KEYTRUDA®Phase 2 · Melanoma Stage IIIClinicalTrials.gov · fetched Nov 12, 2026
- L19IL2Phase 2 · Locally Advanced Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- L19IL2Phase 2 · Melanoma Stage IIIClinicalTrials.gov · fetched Nov 12, 2026
- L19IL2/L19TNFPhase 2 · Locally Advanced Cutaneous Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- L19IL2/L19TNFPhase 2 · Locally Advanced Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- L19IL2/L19TNFPhase 2 · Melanoma Stage IIIClinicalTrials.gov · fetched Nov 12, 2026
- L19TNFPhase 2 · Locally Advanced Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- L19TNFPhase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- L19TNFPhase 2 · Melanoma Stage IIIClinicalTrials.gov · fetched Nov 12, 2026
- L19TNF plus doxorubicinPhase 2 · LeiomyosarcomaClinicalTrials.gov · fetched Nov 12, 2026
- LomustinePhase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- DOXORUBICINPhase 1 · Soft Tissue SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- L19TNFPhase 1 · Soft Tissue SarcomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)PHASE2 · RECRUITING · started Sep 28, 2026ClinicalTrials.gov NCT07227350 · fetched Nov 12, 2026
- L19IL2/L19TNF in Patients With Cutaneous Squamous Cell CarcinomaPHASE2 · RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07228442 · fetched Nov 12, 2026
- L19IL2/TNF in Patients With Basal Cell CarcinomaPHASE2 · RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07227870 · fetched Nov 12, 2026
- Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma PatientsPHASE2 · RECRUITING · started Jul 12, 2024ClinicalTrials.gov NCT06284590 · fetched Nov 12, 2026
- A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or RecurrencePHASE2 · ACTIVE_NOT_RECRUITING · started May 22, 2024ClinicalTrials.gov NCT06336291 · fetched Nov 12, 2026
- Dose Finding Study of L19TNF and Doxorubicin in Patients With STSPHASE1 · UNKNOWN · started Sep 5, 2019ClinicalTrials.gov NCT04032964 · fetched Nov 12, 2026
- Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)PHASE2 · UNKNOWN · started Dec 27, 2018ClinicalTrials.gov NCT03420014 · fetched Nov 12, 2026
- Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma PatientsPHASE3 · RECRUITING · started Sep 20, 2018ClinicalTrials.gov NCT03567889 · fetched Nov 12, 2026